Back to companies

Nabriva Therapeutics Plc: Executives

Get in touch about GlobalData Company reports

Contact the team or request a demo to find out how our data can drive your business forward

Select Item

The following section provides information on Nabriva Therapeutics Plc’s senior management, executives, CEO and key decision makers and their roles in the organization. For more insight into Nabriva Therapeutics Plc's management and employees, unlock the full data with our company analytics monitoring tool.

Executives

Daniel Burgess

Chairman Executive Board Since: 2017 Age: 61

Daniel Dolan

Chief Financial Officer Senior Management Since: 2021 Age: 46

Christopher Naftzger

Chief Executive Officer - Interim; General Counsel; Secretary Senior Management Since: 2021 Age: 55

Carrie Bourdow

Director Non Executive Board Since: 2017 Age: 60

Colin Broom

Director Non Executive Board Since: 2017 Age: 67
Gain a 360-degree view of Nabriva Therapeutics Plc and make more informed decisions for your business Gain a 360-degree view of Nabriva Therapeutics Plc and make more informed decisions for your business Register your interest
Still looking?

Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.

Explorer

Access more premium companies when you subscribe to Explorer